top of page
  • yoramlevi6

First Look at Newly Released Pfizer Docs, Part 2: The ‘not necessary’ safety studies

"What’s interesting is that the confidential nonclinical overview report was approved in February 2021, around the same time the ‘Cumulative analysis of post-authorization adverse event reports’ which I analysed for Trial Site News, alarmingly it included an appendix listing 8 pages of vaccine adverse events, many of which included central nervous system, respiratory and cardiovascular AEs, among others. The data was collected from Dec 1, 2020 through to February 28, 2021. This tells us that Pfizer and the FDA were made aware of these AEs occurring around that time-period, but Pfizer chose to not conduct any safety pharmacology studies because they weren’t deemed ‘necessary.’"



1 weergave0 opmerkingen

Kommentare


bottom of page